News & Updates

Show Multimedia Only

Transcutaneous neuromodulation improves symptoms in functional dyspepsia

29 Nov 2023

Patients with functional dyspepsia (FD) may benefit from transcutaneous neuromodulation (TN) treatment, which can significantly improve symptoms and quality of life, according to a study.

Transcutaneous neuromodulation improves symptoms in functional dyspepsia

29 Nov 2023

Continuous vs intermittent feeding: Which is better for critically ill patients?

29 Nov 2023 by

Continuous feeding appears to be more effective than intermittent feeding in reducing the rate of mortality in critically ill patients in the intensive care unit (ICU), reveals a study.

Continuous vs intermittent feeding: Which is better for critically ill patients?

29 Nov 2023

Simplified, tailored treatment for asthma improves patient outcomes

29 Nov 2023 by

Asthma is a highly prevalent disease that can affect anybody regardless of age, race, and location. The overall burden of asthma remains severe. Despite the range of available therapies and well-established guidelines, there remains a significant unmet need in the management of asthma. [BMC Public Health 2012;12:860; Respir Res 2023;24:169; Eur Respir J 2014;43:343-373]

Simplified, tailored treatment for asthma improves patient outcomes

29 Nov 2023

Pre-eclampsia ups venous thromboembolism risk during pregnancy

29 Nov 2023

Women with a history of pre-eclampsia are at increased risk of venous thromboembolism during pregnancy, according to a study.

Pre-eclampsia ups venous thromboembolism risk during pregnancy

29 Nov 2023

COVID-19 infection ups CV risk in people living with HIV

29 Nov 2023 by

People living with HIV (PLWH) who were diagnosed with COVID-19 had a 35-percent higher risk of a major cardiovascular (CV) event in the following year than PLWH without COVID in a Spanish study.

COVID-19 infection ups CV risk in people living with HIV

29 Nov 2023

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

28 Nov 2023 by

Viral suppression is maintained through 48 weeks in adults with HIV-1 harbouring drug resistance mutations, who switched to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) fixed-dose combination pill from a boosted protease inhibitor (bPI) therapy, according to recent data from the phase IV open-label PIBIK trial.

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

28 Nov 2023

Some signal of benefit found for liberal transfusion strategy for anaemic heart attack patients

28 Nov 2023 by

Adopting a liberal blood transfusion strategy in patients with acute myocardial infarction (AMI) and anaemia does not appear to do much in terms of reducing the risk of AMI recurrence or death compared with a restrictive transfusion strategy, although there appears to be a hint of benefit, as shown in the results of the phase III MINT trial.

Some signal of benefit found for liberal transfusion strategy for anaemic heart attack patients

28 Nov 2023

HRV/EV infections affect the respiratory system, yield low mortality rates

28 Nov 2023

The respiratory system is the main target of human rhinovirus/enterovirus (HRV/EV) infections, which show a clinical course with low mortality rates, reveals a study.

HRV/EV infections affect the respiratory system, yield low mortality rates

28 Nov 2023

Givosiran delivers safe, sustained improvements in acute hepatic porphyria

28 Nov 2023 by

Long-term monthly treatment with givosiran has good tolerability and offers continuous improvements to patients with acute hepatic porphyria (AHP), results of the phase III ENVISION trial have shown.

Givosiran delivers safe, sustained improvements in acute hepatic porphyria

28 Nov 2023

Omega 6 fatty acids do not influence AF development

28 Nov 2023

Biomarkers of omega 6 (n‒6) fatty acids, including linoleic acid (LA) and arachidonic acid (AA), show no significant relationship with incident atrial fibrillation (AF), a study has found.

Omega 6 fatty acids do not influence AF development

28 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Transcutaneous neuromodulation improves symptoms in functional dyspepsia

Transcutaneous neuromodulation improves symptoms in functional dyspepsia

Continuous vs intermittent feeding: Which is better for critically ill patients?

Continuous vs intermittent feeding: Which is better for critically ill patients?

Simplified, tailored treatment for asthma improves patient outcomes

Simplified, tailored treatment for asthma improves patient outcomes

Pre-eclampsia ups venous thromboembolism risk during pregnancy

Pre-eclampsia ups venous thromboembolism risk during pregnancy

COVID-19 infection ups CV risk in people living with HIV

COVID-19 infection ups CV risk in people living with HIV

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

PIBIK: Switching to B/F/TAF maintains HIV suppression through 48 weeks

Some signal of benefit found for liberal transfusion strategy for anaemic heart attack patients

Some signal of benefit found for liberal transfusion strategy for anaemic heart attack patients

HRV/EV infections affect the respiratory system, yield low mortality rates

HRV/EV infections affect the respiratory system, yield low mortality rates

Givosiran delivers safe, sustained improvements in acute hepatic porphyria

Givosiran delivers safe, sustained improvements in acute hepatic porphyria

Omega 6 fatty acids do not influence AF development

Omega 6 fatty acids do not influence AF development